183 related articles for article (PubMed ID: 24268382)
1. Audit of the autoantibody test, EarlyCDT®-lung, in 1600 patients: an evaluation of its performance in routine clinical practice.
Jett JR; Peek LJ; Fredericks L; Jewell W; Pingleton WW; Robertson JF
Lung Cancer; 2014 Jan; 83(1):51-5. PubMed ID: 24268382
[TBL] [Abstract][Full Text] [Related]
2. Autoantibody Signature Enhances the Positive Predictive Power of Computed Tomography and Nodule-Based Risk Models for Detection of Lung Cancer.
Massion PP; Healey GF; Peek LJ; Fredericks L; Sewell HF; Murray A; Robertson JF
J Thorac Oncol; 2017 Mar; 12(3):578-584. PubMed ID: 27615397
[TBL] [Abstract][Full Text] [Related]
3. EarlyCDT-Lung: an immunobiomarker test as an aid to early detection of lung cancer.
Lam S; Boyle P; Healey GF; Maddison P; Peek L; Murray A; Chapman CJ; Allen J; Wood WC; Sewell HF; Robertson JF
Cancer Prev Res (Phila); 2011 Jul; 4(7):1126-34. PubMed ID: 21733826
[TBL] [Abstract][Full Text] [Related]
4. Detection in blood of autoantibodies to tumour antigens as a case-finding method in lung cancer using the EarlyCDT®-Lung Test (ECLS): study protocol for a randomized controlled trial.
Sullivan FM; Farmer E; Mair FS; Treweek S; Kendrick D; Jackson C; Robertson C; Briggs A; McCowan C; Bedford L; Young B; Vedhara K; Gallant S; Littleford R; Robertson J; Sewell H; Dorward A; Sarvesvaran J; Schembri S
BMC Cancer; 2017 Mar; 17(1):187. PubMed ID: 28284200
[TBL] [Abstract][Full Text] [Related]
5. EarlyCDT®-Lung test: improved clinical utility through additional autoantibody assays.
Chapman CJ; Healey GF; Murray A; Boyle P; Robertson C; Peek LJ; Allen J; Thorpe AJ; Hamilton-Fairley G; Parsy-Kowalska CB; MacDonald IK; Jewell W; Maddison P; Robertson JF
Tumour Biol; 2012 Oct; 33(5):1319-26. PubMed ID: 22492236
[TBL] [Abstract][Full Text] [Related]
6. Performance of the EarlyCDT® Lung test in detection of lung cancer and pulmonary metastases in a high-risk cohort.
Borg M; Wen SWC; Nederby L; Hansen TF; Jakobsen A; Andersen RF; Weinreich UM; Hilberg O
Lung Cancer; 2021 Aug; 158():85-90. PubMed ID: 34130044
[TBL] [Abstract][Full Text] [Related]
7. Performance of a multiplexed dual analyte immunoassay for the early detection of non-small cell lung cancer.
Doseeva V; Colpitts T; Gao G; Woodcock J; Knezevic V
J Transl Med; 2015 Feb; 13():55. PubMed ID: 25880432
[TBL] [Abstract][Full Text] [Related]
8. Application of a high throughput method of biomarker discovery to improvement of the EarlyCDT(®)-Lung Test.
Macdonald IK; Murray A; Healey GF; Parsy-Kowalska CB; Allen J; McElveen J; Robertson C; Sewell HF; Chapman CJ; Robertson JF
PLoS One; 2012; 7(12):e51002. PubMed ID: 23272083
[TBL] [Abstract][Full Text] [Related]
9. Earlier diagnosis of lung cancer in a randomised trial of an autoantibody blood test followed by imaging.
Sullivan FM; Mair FS; Anderson W; Armory P; Briggs A; Chew C; Dorward A; Haughney J; Hogarth F; Kendrick D; Littleford R; McConnachie A; McCowan C; McMeekin N; Patel M; Rauchhaus P; Ritchie L; Robertson C; Robertson J; Robles-Zurita J; Sarvesvaran J; Sewell H; Sproule M; Taylor T; Tello A; Treweek S; Vedhara K; Schembri S;
Eur Respir J; 2021 Jan; 57(1):. PubMed ID: 32732334
[TBL] [Abstract][Full Text] [Related]
10. A cancer/testis antigen microarray to screen autoantibody biomarkers of non-small cell lung cancer.
Shan Q; Lou X; Xiao T; Zhang J; Sun H; Gao Y; Cheng S; Wu L; Xu N; Liu S
Cancer Lett; 2013 Jan; 328(1):160-7. PubMed ID: 22922091
[TBL] [Abstract][Full Text] [Related]
11. Anti-alpha-enolase autoantibodies are down-regulated in advanced cancer patients.
Shih NY; Lai HL; Chang GC; Lin HC; Wu YC; Liu JM; Liu KJ; Tseng SW
Jpn J Clin Oncol; 2010 Jul; 40(7):663-9. PubMed ID: 20395242
[TBL] [Abstract][Full Text] [Related]
12. Detection of lung cancer in silicosis patients using a tumor-marker panel.
Schneider J
Cancer Biomark; 2010; 6(3-4):137-48. PubMed ID: 20660960
[TBL] [Abstract][Full Text] [Related]
13. A fuzzy-classifier using a marker panel for the detection of lung cancers in asbestosis patients.
Schneider J; Bitterlich N; Kotschy-Lang N; Raab W; Woitowitz HJ
Anticancer Res; 2007; 27(4A):1869-77. PubMed ID: 17649786
[TBL] [Abstract][Full Text] [Related]
14. Significance of tumor-associated autoantibodies in the early diagnosis of lung cancer.
Du Q; Yu R; Wang H; Yan D; Yuan Q; Ma Y; Slamon D; Hou D; Wang H; Wang Q
Clin Respir J; 2018 Jun; 12(6):2020-2028. PubMed ID: 29356386
[TBL] [Abstract][Full Text] [Related]
15. Detection of circulating antibodies to linear peptide antigens derived from ANXA1 and DDX53 in lung cancer.
Wang W; Guan S; Sun S; Jin Y; Lee KH; Chen Y; Wei J
Tumour Biol; 2014 May; 35(5):4901-5. PubMed ID: 24453033
[TBL] [Abstract][Full Text] [Related]
16. Natural autoantibody to MUC1 is a prognostic indicator for non-small cell lung cancer.
Hirasawa Y; Kohno N; Yokoyama A; Kondo K; Hiwada K; Miyake M
Am J Respir Crit Care Med; 2000 Feb; 161(2 Pt 1):589-94. PubMed ID: 10673204
[TBL] [Abstract][Full Text] [Related]
17. Analysis of multidisciplinary lung cancer practice.
Conron M; Phuah S; Steinfort D; Dabscheck E; Wright G; Hart D
Intern Med J; 2007 Jan; 37(1):18-25. PubMed ID: 17199840
[TBL] [Abstract][Full Text] [Related]
18. Cost-effectiveness of an autoantibody test (EarlyCDT-Lung) as an aid to early diagnosis of lung cancer in patients with incidentally detected pulmonary nodules.
Edelsberg J; Weycker D; Atwood M; Hamilton-Fairley G; Jett JR
PLoS One; 2018; 13(5):e0197826. PubMed ID: 29787590
[TBL] [Abstract][Full Text] [Related]
19. Quality of integrated care for patients with nonsmall cell lung cancer: variations and determinants of care.
Ouwens MM; Hermens RR; Termeer RA; Vonk-Okhuijsen SY; Tjan-Heijnen VC; Verhagen AF; Hulscher MM; Marres HA; Wollersheim HC; Grol RP
Cancer; 2007 Oct; 110(8):1782-90. PubMed ID: 17724680
[TBL] [Abstract][Full Text] [Related]
20. Assessment of the EarlyCDT-Lung test as an early biomarker of lung cancer in ever-smokers: A retrospective nested case-control study in two prospective cohorts.
Wu WY; Haider Z; Feng X; Heath AK; Tjønneland A; Agudo A; Masala G; Robbins HA; Huerta JM; Guevara M; Schulze MB; Rodriguez-Barranco M; Vineis P; Tumino R; Kaaks R; Fortner RT; Sieri S; Panico S; Nøst TH; Sandanger TM; Braaten T; Johansson M; Melin B; Johansson M
Int J Cancer; 2023 May; 152(9):2002-2010. PubMed ID: 36305647
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
